Asia Pacific Organ Preservation Solutions Market Forecast to 2028
Asia Pacific Organ Preservation Solutions Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type [University of Wisconsin Solution (UW), Custodiol HTK, Perfadex, Hypothermosol, and Others], Application (Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion, and Others), Organ Type (Kidneys, Liver, Lungs, Heart, and Others), and End User (Organ Transplant Centers, Hospitals, and Specialty Clinics)
$2,100 – $3,500
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Opportunities in Emerging Nations to Propel Asia Pacific Organ Preservation Solutions Market Growth
Emerging regions such as Asia Pacific are growing significantly in biotechnology and pharmaceutical sectors. The governments of countries in these regions are supporting through various initiatives, funding, programs, and conferences. For instance, there are three different and dominating models of practice in developing countries. Besides, the public has embraced the new organ donation system in China. According to a recent web-based poll, 75% of respondents favored donation after cardiac death, and 61% expressed an interest in being a donor. With an annual death toll of 846,510 injury-related fatalities, China has a sizable pool of potential donors.
Donation following cardiac death is also universally approved by transplantation experts; there is a tremendous desire to modify the existing quo and pioneer new procedures in China. The International Transplantation Society has also recognized the new program, which adheres to international ethical norms.
R&D activities in pharmaceutical and biotechnology sectors are growing aggressively. According to the Indian Economic Survey 2021, the Indian pharma market was valued at US$ 42 billion in 2021 and is likely to reach US$ 65 billion by 2024. For fiscal year 2021, the average R&D expenses constituted ~7.2% of the total revenues of the pharma companies. Wockhardt is a leading research-based healthcare firm in Asia Pacific with relevance in pharma, biotechnology, and a chain of advanced super specialty hospitals. For 2021, the company spent Rs 6,217.8 million on R&D, accounting for 66.9% of its turnover. They have spent 15% of their revenues compared to the previous year. Wockhardt’s has three R&D centers in India, and it became the only company in the world to hold QIDP status for six antibiotics.
Asia Pacific Organ Preservation Solutions Market Overview
The Asia Pacific organ preservation solutions market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Asia Pacific is expected to be the fastest-growing region among all other regions. The growth of the market in Asia Pacific is attributed to an increase in minimally invasive procedures, rise in healthcare awareness pertaining to the importance of organ donation, and surge in social media marketing to encourage a positive attitude toward organ donation. Additionally, developing healthcare infrastructure and increasing investments to boost manufacturing capacities are projected to drive the Asia Pacific organ preservation solutions market during the forecast period.
Asia Pacific Organ Preservation Solution Market Revenue and Forecast to 2028 (US$ Million)
Asia Pacific Organ Preservation Solution Market Segmentation
The Asia Pacific organ preservation solution market is segmented into type, application, organ type, end user, and country.
Based on type, the Asia Pacific organ preservation solution market is segmented into university of wisconsin solution, custodiol htk, perfadex, hypothermosol, and others. The university of wisconsin solution segment registered the largest Asia Pacific organ preservation solution market share in 2023.
Based on application, the Asia Pacific organ preservation solution market is segmented into static cold storage, hypothermic machine perfusion, normothermic machine perfusion, and others. The static cold storage segment held the largest Asia Pacific organ preservation solution market share in 2023.
Based on organ type, the Asia Pacific organ preservation solutions market is segmented into kidneys, liver, lungs, heart, and others. The kidney segment held the largest Asia Pacific organ preservation solution market share in 2023.
Based on end user, the Asia Pacific organ preservation solutions market is segmented into organ transplant centers, hospitals, and specialty clinics, The organ transplant centers segment held the largest Asia Pacific organ preservation solution market share in 2023.
Based on country, the Asia Pacific organ preservation solutions market has been categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Japan dominated the Asia Pacific organ preservation solutions market share in 2023.
Accord Healthcare; Dr. Franz Koehler Chemie GmbH; Shanghai Genext Pharmaceutical Technology; TransMedics; and XVIVO Perfusion are the leading companies operating in the Asia Pacific organ preservation solutions market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Publishing status: | |
| Geographical coverage: | |
| Year of Publication: |
According to the research team’ research, the Asia Pacific organ preservation solutions market was valued at US$ 51.04 Million in 2023 and is expected to reach US$ 76.94 Million by 2028, registering a CAGR of 8.6% from 2023 to 2028. Rising need for organ transplantation and increasing prevalence of chronic diseases leading to kidney failure are the critical factors attributed to the Asia Pacific organ preservation solutions market expansion.
CVDs are heart and blood vessel disorders, which include cerebrovascular diseases, coronary heart disease, rheumatic heart disease, and other diseases. Tobacco use, unhealthy diet, and physical inactivity, which increase the risk of heart attacks and strokes, are some of the major causes of death and difficulty. CVDs are the world’s leading cause of death, affecting more than any other disease.
Cardiovascular diseases are becoming more and more prevalent around the world. Cardiovascular diseases are the world’s leading cause of death. Most CVD deaths are followed by a stroke and heart failure due to coronary heart disease (CHD). It is also stated that around 31% of all deaths are caused by cardiovascular diseases worldwide. According to organdonor.gov, the heart is the third-largest vital organ transplantation performed after kidney and liver. Besides, new technologies for a heart transplant will offer lucrative opportunities for the organ preservation solutions market. Technological innovation also has been playing a critical role in increasing the widespread uptake of organ transplantation. For instance, the Transmedics Organ Care System (OCS) Heart or “Heart in a Box,” enables transplant doctors to travel to much farther locations in search of transplant hearts by acting as a miniature intensive care unit that maintains the heart’s viability.
The increasing need for a heart transplant, owing to the increasing prevalence of cardiovascular diseases, is expected to boost the market growth during the prediction period.
On the contrary, expensive organ transplant surgeries hurdles the growth of Asia Pacific organ preservation solutions market.
Based on type, the Asia Pacific organ preservation solutions market is segmented into University of Wisconsin solution, custodiol HTK, perfadex, hypothermosol, and others. The University of Wisconsin solution segment held 39.9% share of Asia Pacific organ preservation solutions market in 2023, amassing US$ 20.37 Million. It is projected to garner US$ 30.74 Million by 2028 to expand at 8.6 % CAGR during 2023–2028.
Based on application, the Asia Pacific organ preservation solutions market is segmented into static cold storage, hypothermic machine perfusion, normothermic machine perfusion, and others. The static cold storage segment held 45.8% share of Asia Pacific organ preservation solutions market in 2023, amassing US$ 23.38 Million. It is projected to garner US$ 35.65 Million by 2028 to expand at 8.8% CAGR during 2023–2028.
Based on organ type, the Asia Pacific organ preservation solutions market is segmented into kidneys, liver, lungs, heart, and others. The kidney segment held 59.3% share of Asia Pacific organ preservation solutions market in 2023, amassing US$ 30.27 Million. It is projected to garner US$ 46.13 Million by 2028 to expand at 8.8% CAGR during 2023–2028.
Based on end user, the Asia Pacific organ preservation solutions market is segmented into organ transplant centers, hospitals, and specialty clinics, The organ transplant centers segment held 54.5% share of Asia Pacific organ preservation solutions market in 2023, amassing US$ 27.83 Million. It is projected to garner US$ 42.48 Million by 2028 to expand at 8.8% CAGR during 2023–2028.
Based on country, the Asia Pacific organ preservation solutions market has been categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Our regional analysis states that Japan captured 31.3% share of Asia Pacific organ preservation solutions market in 2023. It was assessed at US$ 16.03 Million in 2023 and is likely to hit US$ 24.58 Million by 2028, exhibiting a CAGR of 8.9% during the forecast period.
Key players operating in the Asia Pacific organ preservation solutions market are Accord Healthcare; Dr. Franz Koehler Chemie GmbH; Shanghai Genext Pharmaceutical Technology; TransMedics; and XVIVO Perfusion among others.
In June 2019, TransMedics Announces the Second FDA PMA Approval for its OCS Lung System, Allowing Access to a Larger Pool of Donor Lungs that are Currently Seldomly Utilized for Transplantation Due to Limitations of Cold Storage.
o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific organ preservation solution market.
o Highlights key business priorities in order to assist companies to realign their business strategies
o The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific organ preservation solution market, thereby allowing players across the value chain to develop effective long-term strategies
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
o Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the organ preservation solution market as well as those hindering it
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
TABLE OF CONTENTS
1. Introduction
1.1 Study Scope
1.2 The Research Team Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Organ Preservation Solution Market – by Type
1.3.2 Asia Pacific Organ Preservation Solution Market – by Application
1.3.3 Asia Pacific Organ Preservation Solution Market – by Organ Type
1.3.4 Asia Pacific Organ Preservation Solution Market – by End User
1.3.5 Asia Pacific Organ Preservation Solution Market – by Country
2. Asia Pacific Organ Preservation Solution Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Organ Preservation Solution Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific – PEST Analysis
4.3 Expert Opinions
5. Asia Pacific Organ Preservation Solution Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Need for Organ Transplantation
5.1.2 Increasing Prevalence of Chronic Diseases Leading to Kidney Failure
5.1.3 Rising Geriatric Population
5.2 Market Restraints
5.2.1 Expensive Organ Transplant Surgeries
5.2.2 Limited Number of Donors for Organ Transplant Surgeries
5.3 Market Opportunities
5.3.1 Rising Prevalence of Cardiovascular Diseases (CVDs)
5.4 Future Trends
5.4.1 Growth Opportunities in Emerging Nations
5.5 Impact Analysis
6. Organ Preservation Solution Market – Asia Pacific Analysis
6.1 Asia Pacific Organ Preservation Solutions Market Revenue Forecast and Analysis
7. Asia Pacific Organ Preservation Solution Market – Revenue and Forecast to 2028 – by Type
7.1 Overview
7.1.1 Asia Pacific Organ Preservation Solutions Market, By Type 2022 & 2028 (%)
7.2 University of Wisconsin Solution (UW) Market
7.2.1 Overview
7.2.2 University of Wisconsin solution (UW): Asia Pacific Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)
7.3 Custodiol HTKs
7.3.1 Overview
7.3.2 Custodiol HTKs: Asia Pacific Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)
7.4 Perfadex
7.4.1 Overview
7.4.2 Perfadex : Asia Pacific Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)
7.5 Hypothermosol
7.5.1 Overview
7.5.2 Hypothermosol: Asia Pacific Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)
7.6 Others
7.6.1 Overview
7.6.2 Others : Asia Pacific Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)
8. Asia Pacific Organ Preservation Solution Market – Revenue and Forecast to 2028 – by Application
8.1 Overview
8.2 Asia Pacific Organ Preservation Solutions Market Share, by Application, 2022 and 2028 (%)
8.3 Static Cold Storage
8.3.1 Overview
8.3.2 Static Cold Storage: Asia Pacific Organ Preservation Solutions – Revenue and Forecast to 2028 (US$ Thousand)
8.4 Hypothermic Machine Perfusion
8.4.1 Overview
8.5 Normothermic Machine Perfusion
8.5.1 Overview
8.5.2 Normothermic Machine Perfusion: Asia Pacific Organ Preservation Solutions – Revenue and Forecast to 2028 (US$ Thousand)
8.6 Others
8.6.1 Overview
8.6.2 Others: Asia Pacific Organ Preservation Solutions Market– Revenue and Forecast to 2028 (US$ Thousand)
9. Asia Pacific Organ Preservation Solution Market – Revenue and Forecast to 2028 – by Organ Type
9.1 Overview
9.2 Asia Pacific Organ Preservation Solutions Market Share, by Organ Type, 2022 and 2028 (%)
9.3 Heart
9.3.1 Overview
9.3.2 Heart: Asia Pacific Organ Preservation Solutions Market– Revenue and Forecast to 2028 (USD Thousand)
9.4 Lung
9.4.1 Overview
9.4.2 Lung: Asia Pacific Organ Preservation Solutions Market– Revenue and Forecast to 2028 (USD Thousand)
9.5 Kidney
9.5.1 Overview
9.5.2 Kidney: Asia Pacific Organ Preservation Solutions Market– Revenue and Forecast to 2028 (USD Thousand)
9.6 Liver
9.6.1 Overview
9.6.2 Liver: Asia Pacific Organ Preservation Solutions Market– Revenue and Forecast to 2028 (USD Thousand)
9.7 Others
9.7.1 Overview
9.7.2 Others: Asia Pacific Organ Preservation Solutions Market– Revenue and Forecast to 2028 (USD Thousand)
10. Asia Pacific Organ Preservation Solution Market – Revenue and Forecast to 2028 – by End User
10.1 Overview
10.2 Asia Pacific Organ Preservation Solutions Market Share, by End User, 2022 and 2028 (%)
10.3 Organ Transplant Centers
10.3.1 Overview
10.3.2 Organ Transplant Centers: Asia Pacific Organ Preservation Solutions Market– Revenue and Forecast to 2028 (USD Thousand)
10.4 Hospitals
10.4.1 Overview
10.4.2 Hospitals: Asia Pacific Organ Preservation Solutions Market– Revenue and Forecast to 2028 (USD Thousand)
10.5 Specialty Clinics
10.5.1 Overview
10.5.2 Specialty Clinics: Asia Pacific Organ Preservation Solutions Market– Revenue and Forecast to 2028 (USD Thousand)
11. Asia Pacific Organ Preservation Solution Market – Revenue and Forecast to 2028 – Country Analysis
11.1 Asia Pacific: Organ Preservation Solution Market
11.1.1 Overview
11.1.2 Asia Pacific: Organ Preservation Solution Market, by Country, 2022 & 2028 (%)
11.1.2.1 China: Organ Preservation Solution Market – Revenue and Forecast to 2028 (US$ Thousand)
11.1.2.1.1 Overview
11.1.2.1.2 China: Organ Preservation Solution Market – Revenue and Forecast to 2028 (US$ Thousand)
11.1.2.1.3 China: Organ Preservation Solution Market, by Type, 2020–2028 (US$ Thousand)
11.1.2.1.4 China: Organ Preservation Solution Market, by Application, 2020–2028 (US$ Thousand)
11.1.2.1.5 China: Organ Preservation Solution Market, by Organ Type, 2020–2028 (US$ Thousand)
11.1.2.1.6 China: Organ Preservation Solution Market, by End User, 2020–2028 (US$ Thousand)
11.1.2.2 Japan: Organ Preservation Solution Market – Revenue and Forecast to 2028 (US$ Thousand)
11.1.2.2.1 Overview
11.1.2.2.2 Japan: Organ Preservation Solution Market – Revenue and Forecast to 2028 (US$ Thousand)
11.1.2.2.3 Japan: Organ Preservation Solution Market, by Type, 2020–2028 (US$ Thousand)
11.1.2.2.4 Japan: Organ Preservation Solution Market, by Application, 2020–2028 (US$ Thousand)
11.1.2.2.5 Japan: Organ Preservation Solution Market, by Organ Type, 2020–2028 (US$ Thousand)
11.1.2.2.6 Japan: Organ Preservation Solution Market, by End User, 2020–2028 (US$ Thousand)
11.1.2.3 India: Organ Preservation Solution Market – Revenue and Forecast to 2028 (US$ Thousand)
11.1.2.3.1 Overview
11.1.2.3.2 India: Organ Preservation Solution Market – Revenue and Forecast to 2028 (US$ Thousand)
11.1.2.3.3 India: Organ Preservation Solution Market, by Type, 2020–2028 (US$ Thousand)
11.1.2.3.4 India: Organ Preservation Solution Market, by Application, 2020–2028 (US$ Thousand)
11.1.2.3.5 India: Organ Preservation Solution Market, by Organ Type, 2020–2028 (US$ Thousand)
11.1.2.3.6 India: Organ Preservation Solution Market, by End User, 2020–2028 (US$ Thousand)
11.1.2.4 Australia: Organ Preservation Solution Market – Revenue and Forecast to 2028 (US$ Thousand)
11.1.2.4.1 Overview
11.1.2.4.2 Australia: Organ Preservation Solution Market – Revenue and Forecast to 2028 (US$ Thousand)
11.1.2.4.3 Australia: Organ Preservation Solution Market, by Type, 2020–2028 (US$ Thousand)
11.1.2.4.4 Australia: Organ Preservation Solution Market, by Application, 2020–2028 (US$ Thousand)
11.1.2.4.5 Australia: Organ Preservation Solution Market, by Organ Type, 2020–2028 (US$ Thousand)
11.1.2.4.6 Australia: Organ Preservation Solution Market, by End User, 2020–2028 (US$ Thousand)
11.1.2.5 South Korea: Organ Preservation Solution Market – Revenue and Forecast to 2028 (US$ Thousand)
11.1.2.5.1 Overview
11.1.2.5.2 South Korea: Organ Preservation Solution Market – Revenue and Forecast to 2028 (US$ Thousand)
11.1.2.5.3 South Korea: Organ Preservation Solution Market, by Type, 2020–2028 (US$ Thousand)
11.1.2.5.4 South Korea: Organ Preservation Solution Market, by Application, 2020–2028 (US$ Thousand)
11.1.2.5.5 South Korea: Organ Preservation Solution Market, by Organ Type, 2020–2028 (US$ Thousand)
11.1.2.5.6 South Korea: Organ Preservation Solution Market, by End User, 2020–2028 (US$ Thousand)
11.1.2.6 Rest of Asia Pacific: Organ Preservation Solution Market – Revenue and Forecast to 2028 (US$ Thousand)
11.1.2.6.1 Overview
11.1.2.6.2 Rest of Asia Pacific: Organ Preservation Solution Market – Revenue and Forecast to 2028 (US$ Thousand)
11.1.2.6.3 Rest of Asia Pacific: Organ Preservation Solution Market, by Type, 2020–2028 (US$ Thousand)
11.1.2.6.4 Rest of Asia Pacific: Organ Preservation Solution Market, by Application, 2020–2028 (US$ Thousand)
11.1.2.6.5 Rest of Asia Pacific: Organ Preservation Solution Market, by Organ Type, 2020–2028 (US$ Thousand)
11.1.2.6.6 Rest of Asia Pacific: Organ Preservation Solution Market, by End User, 2020–2028 (US$ Thousand)
12. Asia Pacific Organ Preservation Solution Market–Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Organ Preservation Solutions Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 XVIVO Perfusion
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 TransMedics
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Dr. Franz Koehler Chemie GmbH
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Accord Healthcare
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Shanghai Genext Pharmaceutical Technology
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. China Organ Preservation Solution Market, by Type – Revenue and Forecast to 2028 (US$ Thousand)
Table 2. China Organ Preservation Solution Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 3. China Organ Preservation Solution Market, by Organ Type – Revenue and Forecast to 2028 (US$ Thousand)
Table 4. China Organ Preservation Solution Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 5. Japan Organ Preservation Solution Market, by Type – Revenue and Forecast to 2028 (US$ Thousand)
Table 6. Japan Organ Preservation Solution Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 7. Japan Organ Preservation Solution Market, by Organ Type – Revenue and Forecast to 2028 (US$ Thousand)
Table 8. Japan Organ Preservation Solution Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 9. India Organ Preservation Solution Market, by Type – Revenue and Forecast to 2028 (US$ Thousand)
Table 10. India Organ Preservation Solution Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 11. India Organ Preservation Solution Market, by Organ Type – Revenue and Forecast to 2028 (US$ Thousand)
Table 12. India Organ Preservation Solution Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 13. Australia Organ Preservation Solution Market, by Type – Revenue and Forecast to 2028 (US$ Thousand)
Table 14. Australia Organ Preservation Solution Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 15. Australia Organ Preservation Solution Market, by Organ Type – Revenue and Forecast to 2028 (US$ Thousand)
Table 16. Australia Organ Preservation Solution Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 17. South Korea Organ Preservation Solution Market, by Type – Revenue and Forecast to 2028 (US$ Thousand)
Table 18. South Korea Organ Preservation Solution Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 19. South Korea Organ Preservation Solution Market, by Organ Type – Revenue and Forecast to 2028 (US$ Thousand)
Table 20. South Korea Organ Preservation Solution Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 21. Rest of Asia Pacific Organ Preservation Solution Market, by Type – Revenue and Forecast to 2028 (US$ Thousand)
Table 22. Rest of Asia Pacific Organ Preservation Solution Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 23. Rest of Asia Pacific Organ Preservation Solution Market, by Organ Type – Revenue and Forecast to 2028 (US$ Thousand)
Table 24. Rest of Asia Pacific Organ Preservation Solution Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 25. Recent Inorganic Growth Strategies in the Organ Preservation Solutions Market
Table 26. Recent Organic Growth Strategies in the Organ Preservation Solutions Market
Table 27. Glossary of Terms
LIST OF FIGURES
Figure 1. Asia Pacific Organ Preservation Solution Market Segmentation
Figure 2. Asia Pacific Organ Preservation Solution Market, by region
Figure 3. Asia Pacific Organ Preservation Solution Market Overview
Figure 4. University of Wisconsin solution (UW) Segment Held Largest Share of Type Segment in Organ Preservation Solution Market
Figure 5. Japan Expected to Show Remarkable Growth During Forecast Period
Figure 6. Asia Pacific PEST Analysis
Figure 7. Asia Pacific Organ Preservation Solutions Market Impact Analysis of Drivers and Restraints
Figure 8. Asia Pacific Organ Preservation Solutions Market – Revenue Forecast and Analysis – 2020- 2028
Figure 9. Asia Pacific Organ Preservation Solutions Market, By Type 2022 & 2028 (%)
Figure 10. University of Wisconsin solution (UW): Asia Pacific Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 11. Custodiol HTKs: Asia Pacific Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 12. Perfadex: Asia Pacific Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 13. Hypothermosol: Asia Pacific Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 14. Others: Asia Pacific Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 15. Asia Pacific Organ Preservation Solutions Market Share, by Application, 2022 and 2028 (%)
Figure 16. Static Cold Storage: Asia Pacific Organ Preservation Solutions – Revenue and Forecast to 2028 (US$ Thousand)
Figure 17. Hypothermic Machine Perfusion: Asia Pacific Organ Preservation Solutions Market– Revenue and Forecast to 2028 (US$ Thousand)
Figure 18. Normothermic Machine Perfusion: Asia Pacific Organ Preservation Solutions Market– Revenue and Forecast to 2028 (US$ Thousand)
Figure 19. Others: Asia Pacific Organ Preservation Solutions Market– Revenue and Forecast to 2028 (US$ Thousand)
Figure 20. Asia Pacific Organ Preservation Solutions Market Share, by Organ Type, 2022 and 2028 (%)
Figure 21. Heart: Asia Pacific Organ Preservation Solutions Market– Revenue and Forecast to 2028 (USD Thousand)
Figure 22. Lung: Asia Pacific Organ Preservation Solutions Market– Revenue and Forecast to 2028 (USD Thousand)
Figure 23. Kidney: Asia Pacific Organ Preservation Solutions Market– Revenue and Forecast to 2028 (USD Thousand)
Figure 24. Liver: Asia Pacific Organ Preservation Solutions Market– Revenue and Forecast to 2028 (USD Thousand)
Figure 25. Others: Asia Pacific Organ Preservation Solutions Market– Revenue and Forecast to 2028 (USD Thousand)
Figure 26. Asia Pacific Organ Preservation Solutions Market Share, by End User, 2022 and 2028 (%)
Figure 27. Organ Transplant Centers: Asia Pacific Organ Preservation Solutions Market– Revenue and Forecast to 2028 (USD Thousand)
Figure 28. Hospitals: Asia Pacific Organ Preservation Solutions Market– Revenue and Forecast to 2028 (USD Thousand)
Figure 29. Specialty Clinics: Asia Pacific Organ Preservation Solutions Market– Revenue and Forecast to 2028 (US Thousand)
Figure 30. Asia Pacific: Organ Preservation Solution Market, by Key Country – Revenue (2022) (US$ Thousand)
Figure 31. Asia Pacific: Organ Preservation Solution Market, by Country, 2022 & 2028 (%)
Figure 32. China: Organ Preservation Solution Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 33. Japan: Organ Preservation Solution Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 34. India: Organ Preservation Solution Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 35. Australia: Organ Preservation Solution Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 36. South Korea: Organ Preservation Solution Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 37. Rest of Asia Pacific: Organ Preservation Solution Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 38. Growth Strategies in the Organ Preservation Solutions Market
The List of Companies – Asia Pacific Organ Preservation Solutions Market
o Accord Healthcare
o Dr. Franz Koehler Chemie GmbH
o Shanghai Genext Pharmaceutical Technology
o TransMedics
o XVIVO Perfusion
You must be logged in to post a review.
Reviews
There are no reviews yet.